Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Rights Issue
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

Corporate Presentations

  • 27 May 2025

    Presentation to Investors

  • 28 Nov 2024

    Presentation to Annual General Meeting

  • 26 Jun 2024

    Biotron Clinical Trial Results Webinar

  • 22 Nov 2023

    Presentation to Annual General Meeting

  • 24 Oct 2023

    Presentation to Investors

  • 11 Nov 2022

    Presentation to Investors

  • 25 Nov 2021

    Presentation to Investors

  • 23 Nov 2021

    Presentation to Annual General Meeting

  • 7 Oct 2021

    Presentation to Investors

  • 19 Nov 2020

    Presentation to Annual General Meeting

  • 1
  • 2
  • 3
  • 4
  • 5
  • >>

Investor Centre

  • Investor Centre
    • ASX Announcements
    • Annual reports
    • Corporate Directory
    • Shareholder services
    • Top 40 Shareholders
    • Top 40 Option Holders
    • Corporate Governance
    • Corporate Presentations
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 25 June 2025        Legal Notices and Privacy
Cleantalk Pixel